Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
ORIGINAL ARTICLE
Open Access

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi

Holly M. Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, Silver Wevill, Lalitha Venkatasubramanian, Leila Dal Santo and Bagrey Ngwira
Global Health: Science and Practice March 2019, GHSP-D-18-00433; https://doi.org/10.9745/GHSP-D-18-00433
Holly M. Burke
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hburke{at}fhi360.org
Mario Chen
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercy Buluzi
bCollege of Medicine, University of Malawi, Blantyre, Malawi.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachael Fuchs
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silver Wevill
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lalitha Venkatasubramanian
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leila Dal Santo
aFHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bagrey Ngwira
bCollege of Medicine, University of Malawi, Blantyre, Malawi.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Next
  • Article
  • Info & Metrics
  • Comments
  • PDF
Loading

Community health workers can adequately provide DMPA-SC directly or train women on self-injection.

ABSTRACT

Objective: To assess the supply- and demand-side factors influencing continued use of the injectable contraceptive subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Methods: We conducted a 12-month randomized controlled trial in Malawi to measure DMPA-SC continuation rates. A total of 731 women presenting to clinic-based providers (CBPs) at 6 Ministry of Health clinics or to community health workers (CHWs) in rural communities were randomized to receive DMPA-SC administered by a provider or be trained to self-inject DMPA-SC. Data collectors contacted women after the reinjection window at 3, 6, and 9 months to collect data on discontinuation and women’s experiences. Twelve months after enrollment or at early discontinuation, women had their final interview, including pregnancy testing. We compared continuation, pregnancy, and safety by whether DMPA-SC or self-injection training was provided by CHWs versus CBPs. We also conducted an exploratory analysis assessing the association between women’s sociodemographic factors and the risk for discontinuation using stratified Cox proportional hazards models.

Findings: The type of provider did not seem to influence continuation, pregnancy, or safety. As reported previously, women in the self-injection group were significantly less likely to discontinue the method compared with women in the provider-administered group (hazard ratio, 0.43; P<.001). The risk for discontinuation was also different among health facility catchment sites (P<.001). No other assessed sociodemographic factors were found to significantly influence the risk for discontinuation.

Conclusions: Public-sector CHWs can safely and effectively provide DMPA-SC and train women to self-inject DMPA-SC in low-resource settings. DMPA-SC continuation did not seem to be influenced by the type of provider, whether CBP or CHW, or women’s sociodemographic characteristics.

  • Received: 2018 Nov 2.
  • Accepted: 2019 Jan 16.
  • © Burke et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-18-00433

Next
Back to top

In this issue

Global Health: Science and Practice: 13 (2)
Global Health: Science and Practice
Vol. 13, No. 2
December 31, 2025
  • Table of Contents
  • About the Cover
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi
Holly M. Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, Silver Wevill, Lalitha Venkatasubramanian, Leila Dal Santo, Bagrey Ngwira
Global Health: Science and Practice Mar 2019, GHSP-D-18-00433; DOI: 10.9745/GHSP-D-18-00433

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi
Holly M. Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, Silver Wevill, Lalitha Venkatasubramanian, Leila Dal Santo, Bagrey Ngwira
Global Health: Science and Practice Mar 2019, GHSP-D-18-00433; DOI: 10.9745/GHSP-D-18-00433
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos
  • Another Best Practice: Leveraging User and Stakeholder Perspectives to Improve and Refine Existing Medical Products
  • Self-injected contraceptives: does the investment reflect womens preferences?
  • Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results
  • Google Scholar

More in this TOC Section

  • Patterns and Drivers of Packaged (Fortified) Maize Flour Purchase in Urban and Peri-Urban Kenya
  • Exploring a Road Map to Achieving Tobacco Endgame in sub-Saharan Africa: A Qualitative Study Among Stakeholders From 12 Countries
  • Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study
Show more ORIGINAL ARTICLE

Similar Articles

Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire